课题基金 / 基金详情

Comprehensive study about the neoplastic characterization of benign and malignant smooth muscle tumor arising in the uterus

Comprehensive study about the neoplastic characterization of benign and malignant smooth muscle tumor arising in the uterus
子宫良恶性平滑肌瘤肿瘤特征的综合研究
批准号:
10470345
负责人:
FUJII Shingo
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

FUJII Shingo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clinical observations, that a large number of mast cells containing heparin reside in leiomyoma and that leiomyoma often enlarge rapidly during pregnancy, encouraged us to study the effect of heparin and HCG on the growth of leiomyomal cells. Then, heparin inhibited the proliferation of leiomyomal cells through the induction of α-smooth muscle actin (SMA), calponin h1 and p27. This suggests that heparin from mast cells may induce differentiation in leiomyomal cells and may influence tissue remodeling and reconstruction during tumorgenesis of leiomyoma. In contrast, HCG directly promoted the proliferation of leiomyomal cells and the result was compatible with the clinical observation.To determine the genetic difference of smooth muscle tumors the uterus, the expression of estrogen receptors (ER), progesterone receptors (PR), tumor suppressor concogene p53, Ki-67, cyclin E, cyclin A, cdk2, cdc2 and calponin h1 was examined in smooth muscle tumors of the uterus. Then, reduced expression o … More f ER, PR and calponin h1 with increased expression of p53, Ki-67, cyclin E, cyclin A, cdk2, and cdc2 was associated in leiomyosarcomas of the uterus. The vice versa results were obtained in leiomyoma.Uterine leiomyosarcoma is a rare, but lethal, tumor. The genetic analysis of leiomyosarcoma has revealed that this tumor exhibits a diminished expression of calponin h1, which is normally expressed in smooth muscle cells of healthy myometria and in leiomyoma (a benign tumor of smooth muscle). Transfection of the calponin h1 gene into human leiomyosarcoma cells resulted in morphologic modifications that resembled the appearance of cultured normal myometrial smooth muscle cells. Furthermore, in vivo tumorgenicity was significantly reduced by this treatment. Therefore, calponin h1 is a prospective tumor suppressor for leiomyosarcoma. Clinically, the transfer of calponin h1 cDNA into poorly differentiated leiomyosarcoma cells could have therapeutic potential through induction of a normal, differentiated cellular phenotype. Less
期刊论文(86)
专著(0)
科研奖励(0)
会议论文
Ya-Li Zhai et al.: "Uterine leiomyosarcoma has abnormal expression of sex steroid receptors, Ki-67, and p53 compared to the other smooth muscle tumors of the uterus" Internationsl Journal of Gynecologic Pathology. 18. 20-28 (1999)
Ya-Li Zhai 等人:“与其他子宫平滑肌肿瘤相比,子宫平滑肌肉瘤具有性类固醇受体、Ki-67 和 p53 的异常表达”,《国际妇科病理学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Akiko Horiuchi et al.: "Reduced expression of calponin h1 in leiomyosarcoma of the uterus" Lavoratory Investigation. 78. 839-846 (1998)
Akiko Horiuchi 等人:“子宫平滑肌肉瘤中钙调蛋白 h1 的表达减少”实验室调查。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ya-Li Zhai et al.: "Expression of cyclins and cyclin dependent kinases in smooth muscle tumors of the uterus" International Journal of Cancer. in press.
Ya-Li Zhai 等人:“子宫平滑肌肿瘤中细胞周期蛋白和细胞周期蛋白依赖性激酶的表达”国际癌症杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
35
    Development of therapeutic and prophylactic method for the uterine smooth muscle tumors bu understanding novel aspect of its etiology
    Development of new therapeutic modalities based on the analysis of the pathogenesis and biological features of leiomyoma
    • 批准号:
      13307047
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.45万
    • 财政年份:
      2001
    • 负责人:
      FUJII Shingo
    • 依托单位:
    Characterization of tumorigenic features of uterine leiomyoma
    • 批准号:
      08457438
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.74万
    • 财政年份:
      1996
    • 负责人:
      FUJII Shingo
    • 依托单位:
    Reconsideration of Sex-steroid Receptor Regulatory Mechanism in the Female Genital Tract
    • 批准号:
      05454442
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.22万
    • 财政年份:
      1993
    • 负责人:
      FUJII Shingo
    • 依托单位: